HOME >> MEDICINE >> NEWS
New data provide further evidence of effectiveness of targeted delivery of Relenza and efficacy in both A&B strains

San Francisco, 28 September, 1999: The targeted delivery of Relenza results in high concentrations of the drug in the primary site of viral replication, the lungs, up to 24 hours after inhalation. It is also effective against A& B strain influenza, and reduces complications requiring antibiotics. These are the conclusions from three studies of Relenza (zanamivir), the new anti-flu treatment, being presented to physicians at a major anti-viral conference.

The data presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 26-29, in San Francisco, USA, provide further evidence of the effectiveness of Relenza, and its highly targeted mode of administration, against both A & B strains of influenza.

Results from a laboratory study, presented at ICAAC1, showed that the inhalation of Relenza resulted in a high concentration of the drug in the lungs. These levels of the drug allow for continued anti-viral activity at the major site of viral replication and were retained up to 24 hours after a single 10mg inhaled dose. These data strongly support the use of an inhaled therapy that delivers its effect direct to the site of major viral replication.

A further benefit of the high concentrations achieved in the respiratory tract is that the possibility of development of resistance to the drug is reduced. Other influenza anti-virals have been of limited clinical use because the virus can often develop resistance to them rapidly.

The efficacy of the drug against influenza B was demonstrated by a meta-analysis of 220 patients, with confirmed B strain flu, from a total of 1,572 patients involved in five placebo-controlled studies. Using a regimen of 10mg twice daily (bid) for five days2, time to alleviation of symptoms (the primary endpoint) was reduced by 25 per cent to 4.5 days for those taking Relenza, down from 6.0 days for those on placebo.

The results of this analysis confirm the efficacy of Relenza in
'"/>

Contact: Jeremy Payne
jyp96669@glaxowellcome.co.uk
44-181-966-4719
CPR Worldwide
28-Sep-1999


Page: 1 2

Related medicine news :

1. Study provides new estimates of the causes of child mortality worldwide
2. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
3. End AIDS drug waiting lists, HIV care providers tell policymakers
4. Artery clearing system does not provide benefit for patients undergoing PCI
5. Newly identified gene cluster on mouse X chromosome provides insights into fertility
6. University of Washington joins new Autism Treatment Network to provide better medical services
7. Rat whisking may provide insight into debilitating eye disorder
8. Researchers hope monkeys can provide new insights into depression
9. AGI and USGS provide unique tsunami disaster relief
10. New ITN Scholars Program provides junior faculty opportunity to develop clinical trials expertise
11. Pegaptanib provides benefit for neovascular age-related macular degeneration

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2018)... CHICAGO (PRWEB) , ... August 31, 2018 , ... ... community hospitals | 2018" list. , This list includes independent community hospitals as ... geographies, while others care for small communities outside of large cities. The hospitals ...
(Date:8/31/2018)... ... August 31, 2018 , ... Kessler ... the addition of an MRI Simulator. In the MRI Simulator, the individual experiences ... engaging in this mock scan experience, research participants become accustomed to the sights ...
(Date:8/31/2018)... ... August 31, 2018 , ... The ... Heart Association (AHA) to be responsive for procurement purposes. , A 100 million ... now reap the benefits. Companies like Pacific Medical Training are already offering VA ...
(Date:8/31/2018)... ... August 31, 2018 , ... Rudina Thanasi, ... of a biofield energy treated nutraceutical to improve overall immunity and to combat ... and blood, as well as, inflammation. The following data was reported:, ...
(Date:8/31/2018)... AMES, Iowa (PRWEB) , ... August 31, 2018 , ... ... demonstration jump as part of the Iowa State Cyclones season opener game. At 7pm, ... game, right as the National Anthem starts to play, Team Fastrax™ will jump in ...
Breaking Medicine News(10 mins):
(Date:9/1/2018)... ... 2018 , ... New England College of Optometry (NECO) and ... Dean of Academic Affairs. Reporting directly to the President of the College, the ... officer responsible for the faculty and the related administrative departments that support the ...
(Date:9/1/2018)... FREDERICK, Md. (PRWEB) , ... September 01, 2018 , ... ... infections like Lyme disease, will be hosting the Getting Rid of Lyme Disease Issues ... Frederick Innovative Technology Center Inc. (FITCI) , Lyme Disease is the number one vector ...
(Date:8/31/2018)... ... August 31, 2018 , ... Power Systems, a leading ... and endurance brand, have partnered in a shared mission to motivate 100 million people ... has been on the rise since 2010, offering competitors a fun and complete physical ...
Breaking Medicine Technology:
Cached News: